olanzapin pfizer 20 mg tabletta
pfizer kft. - olanzapin -
omeprazol pfizer 10 mg gyomornedv-ellenálló kemény kapszula
pfizer kft. - omeprazol -
omeprazol pfizer 20 mg gyomornedv-ellenálló kemény kapszula
pfizer kft. - omeprazol -
omeprazol pfizer 40 mg gyomornedv-ellenálló kemény kapszula
pfizer kft. - omeprazol -
sertraline pfizer 50 mg filmtabletta
pfizer kft. - szertralin -
ondansetron pfizer 4 mg filmtabletta
pfizer kft. - ondansetron -
ondansetron pfizer 8 mg filmtabletta
pfizer kft. - ondansetron -
ramipril/amlodipin pfizer 2,5 mg/2,5 mg hartkapseln
pfizer corporation austria gmbh - amlodipin besilat; ramipril -
pemetrexed pfizer (previously pemetrexed hospira)
pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastilised ained - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.
pemetrexed pfizer (previously pemetrexed hospira)
pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastiset aineet - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.